CAR T sequencing in myeloma: New discussion frames cilta-cel as a “CAR-first” move even earlier after relapse, with clinicians weighing CAR T vs BCMA bispecifics using patient fitness, comorbidities, relapse pace, and travel logistics. AI in blood cancer tumor boards: A live tumor-board walkthrough shows how AI retrieval tools can speed up decision-making—while flagging HIPAA and compliance pitfalls. FDA HIV update: Gilead’s Bixlenvo (bictegravir/lenacapavir) wins approval as the smallest once-daily single-tablet option for virologically suppressed adults, including those on complex regimens. COVID-19 vaccines: FDA clears multiple 2026–2027 shots targeting the XFG variant for higher-risk groups ahead of fall. Cancer care rule: Nigeria’s federal directive says cancer patients shouldn’t be discharged without arranged continued care or prompt referral. Cyber safety: Pennsylvania warns of fake MyChart messages designed to steal logins and payment details. Device recall: FDA flags Boston Scientific Imager II angiographic catheters for a manufacturing defect that may cause tip degradation/detachment. Workforce & access: ThedaCare highlights radiologic tech pipeline efforts amid imaging staffing shortages. Community health: ChristianaCare adds photo ID checks for adult visitors/patients at major campuses. Rural housing: Parker’s Ponderosa Pines plans 204 workforce units, aiming to keep healthcare and other workers close to jobs. Clinical pipeline: Paxalisib reports a 100% clinical benefit rate in a small metastatic TNBC cohort.